XML 14 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Assets:    
Cash and cash equivalents $ 37,168 $ 13,723
Investments in securities:    
Fixed maturity securities, available-for-sale, at fair value (amortized cost: December 31, 2021: $75,511; December 31, 2020: $112,037) 79,791 117,713
Equity securities, at fair value (cost: December 31, 2021: $29,478; December 31, 2020: $32,478) 76,853 64,919
Short-term investments 45,930 15,170
Other investments 20,298 15,493
Total investments 222,872 213,295
Premium and fees receivable 22,953 19,427
Accrued interest and dividends 817 1,038
Prepaid expenses and other receivables 11,721 9,418
Property, net 13,033 11,160
Goodwill and other intangible assets, net 15,951 9,771
Operating lease, right-of-use asset 5,202 3,533
Other assets 1,771 1,560
Total Assets 331,488 282,925
Liabilities:    
Reserve for claims 36,754 33,584
Accounts payable and accrued liabilities 43,868 36,020
Operating lease, liabilities 5,329 3,669
Current income taxes payable 3,329 638
Deferred income taxes, net 13,121 8,592
Total liabilities 102,401 82,503
Commitments and Contingencies 0 0
Stockholders' Equity:    
Preferred stock (1,000 authorized shares; no shares issued) 0 0
Common stock – no par value (10,000 authorized shares; 1,895 and 1,892 shares issued and outstanding as of December 31, 2021 and 2020, respectively, excluding in each period 292 shares of common stock held by the Company) 0 0
Retained earnings 225,861 196,096
Accumulated other comprehensive income 3,226 4,326
Total shareholders’ equity 229,087 200,422
Total Liabilities and Shareholders’ Equity $ 331,488 $ 282,925